Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
about
Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment.Reasons why West Africa continues to be a hotbed for hepatocellular carcinomaStrategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinomaCase analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenibNEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte ApoptosisTargeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse modelsControlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs.Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.Recent advances in the imaging of hepatocellular carcinomaBiomarkers in preclinical cancer imaging.Low immediate postoperative platelet count is associated with hepatic insufficiency after hepatectomy.Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico.Matrine induces caspase-independent program cell death in hepatocellular carcinoma through bid-mediated nuclear translocation of apoptosis inducing factorDifferential proteomics identification of HSP90 as potential serum biomarker in hepatocellular carcinoma by two-dimensional electrophoresis and mass spectrometry.LncRNAs expression signatures of hepatocellular carcinoma revealed by microarrayAntitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagyAssessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.Liver resection in hepatitis B related-hepatocellular carcinoma: clinical outcomes and safety in elderly patients.Liver resection in hepatitis B-related hepatocellular carcinoma: clinical outcomes and safety in overweight and obese patientsAnalysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologiesThe anti-proliferation effect of Aikete injection on hepatocellular carcinoma in vitro and in vivo.Fibrosis-dependent mechanisms of hepatocarcinogenesisA multidisciplinary approach to the management of hepatocellular carcinoma.Clinical outcomes of compensated and decompensated cirrhosis: A long term study.Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinomaDevelopment and validation of a prediction score for complications after hepatectomy in hepatitis B-related hepatocellular carcinoma patients.PKM2 regulates Gli1 expression in hepatocellular carcinoma.Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity.Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture.Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.Problem of hepatocellular carcinoma in West AfricaUpdates in the management of hepatocellular carcinomaValidation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice.Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transitionIntratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma.Use of transient elastography to predict de novo recurrence after radiofrequency ablation for hepatocellular carcinoma.Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.Upregulation of heat shock proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in tumour tissues is associated with poor outcomes from HBV-related early-stage hepatocellular carcinoma.Tegillarca granosa extract Haishengsu induces apoptosis in human hepatocellular carcinoma cell line BEL-7402 via Fas-signaling pathways.
P2860
Q26741499-90C9583E-1DD5-4D93-BD30-0B0E53D4FC2BQ26772209-488058A2-6FA9-4EF4-A214-FA4AF3A0C56DQ27023495-0687D171-90A0-4DA3-9E68-8897CE9717D7Q28083400-C7FBF877-C405-4AE2-8F6D-E2847A1CF1D0Q28593092-1BB2E258-0A79-401A-87E0-6FF0462F2B08Q28729944-59D0F063-E35D-4CC2-95B5-72293852FB66Q30226462-3D67261A-1BE1-4826-AAAB-7C31C94564D8Q30398077-9CB7D5EB-C9F8-421E-9BB1-8C1F4759EAF4Q30415186-EF947BAD-8DE7-431B-9750-EE1C47F40812Q30416864-CEFBC76C-B547-45C3-8153-C4C21F5C6D87Q33417589-10F3B0BD-40AC-4DBC-BC6B-474A5E4F371DQ33544908-9E8F3809-AC72-48F1-95FB-52256DB82868Q33556739-5AB75B8E-B8EA-49A6-982E-0FFA1466875CQ33580269-4C630C66-77E8-4129-AF86-7C2C6DC87BBDQ33661229-2D4F07CF-4A24-4640-9689-D414A31E8AA0Q33684858-21BE9558-A454-493D-8B9F-376E8F979A52Q33684950-7986BACC-8FD3-4EF6-BE82-485ED59DD5C0Q33718341-1D84C230-FF98-4A34-BB1D-58CA8A0EFADAQ33734225-F3794868-3F0C-4FB6-8FE3-F14A027FC098Q33762901-6E066E15-F33F-4D07-AF50-CBB27E5DA82CQ33839989-71100C69-0F23-4893-A5B6-598EC02983ECQ33865082-E92C6398-38E6-4877-94F4-530F2D399A61Q33916361-4A660A03-76CA-4639-BC9C-8E64D97FEFF4Q33948229-9D0A4F30-6973-49CB-A905-7E08E3713CECQ34049627-E8541681-1B57-4D7E-9AB6-C37BDFEC50E0Q34050844-58CD5A40-B52E-4CE9-96AA-DCD67F6D8A2FQ34293185-539FED14-337B-43EA-9D76-EE0CDDBF1DCAQ34371623-26870F52-6F91-40AD-8FF0-AC5B0204BCFCQ34385204-354A1058-D77A-4562-B1B6-44E6EE8E7C98Q34413462-3EAAE347-C85E-46B6-B87C-02B2966759B0Q34567959-E8FA4563-27F1-48AC-916F-5F28F3DB93F8Q34571160-A8A0F35D-29BB-42B4-944F-621C4E99FE47Q34685225-56A491B3-6CAE-45B5-826B-833C68395AD4Q34756307-BFE9DAD3-C2F8-49AD-AB8D-2CBA5BFFCC8FQ34932446-55EA7D49-876A-4713-9F00-495038438406Q35053501-3608223F-95E0-43B9-9752-F01B6765C136Q35067549-ABE13620-D1EC-46C0-B6EA-BBFADF956A46Q35169398-81282DD9-4EE7-49B6-B65C-5041E9181098Q35197467-A628BF69-7601-4FB3-B711-04BC5FAC354DQ35278136-B5991417-1216-4030-B737-A461623883DA
P2860
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatocellular carcinoma: curr ...... s, diagnosis and therapeutics.
@en
Hepatocellular carcinoma: curr ...... s, diagnosis and therapeutics.
@nl
type
label
Hepatocellular carcinoma: curr ...... s, diagnosis and therapeutics.
@en
Hepatocellular carcinoma: curr ...... s, diagnosis and therapeutics.
@nl
prefLabel
Hepatocellular carcinoma: curr ...... s, diagnosis and therapeutics.
@en
Hepatocellular carcinoma: curr ...... s, diagnosis and therapeutics.
@nl
P2093
P2860
P356
P1476
Hepatocellular carcinoma: curr ...... rs, diagnosis and therapeutics
@en
P2093
Mohamed I F Shariff
Shahid A Khan
Simon D Taylor-Robinson
Wladyslaw Gedroyc
P2860
P304
P356
10.1586/EGH.09.35
P577
2009-08-01T00:00:00Z